0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Atrial Fibrillation/Flutter
 101-107 of 107 Articles
Original Investigation |  FREE
Mark H. Eckman, MD; Rodney H. Falk, MD; Stephen G. Pauker, MD
Arch Intern Med. 1998;158(15):1669-1677. doi:10.1001/archinte.158.15.1669.

Editorial | 
Gregory W. Albers, MD
Arch Intern Med. 1998;158(14):1487-1491. doi:10.1001/archinte.158.14.1487.

Autopsy and Medicine | 
Johannes Bjornsson, MD; Randy Hanzlick, MD; and the Autopsy Committee of the College of American Pathologists
Arch Intern Med. 1998;158(13):1399-1400. doi:10.1001/archinte.158.13.1399.

Original Investigation |  FREE
Atrial Fibrillation Investigators: Atrial Fibrillation, Aspirin, Anticoagulation Study; European Atrial Fibrillation Study; Stroke Prevention in Atrial Fibrillation Study; Boston Area Anticoagulation Trial for Atrial Fibrillation Study; Canadian Atrial Fibrillation Study; Veterans Affairs Prevention in Atrial Fibrillation Study
Arch Intern Med. 1998;158(12):1316-1320. doi:10.1001/archinte.158.12.1316.

Editor's Correspondence | 
Victor J. Castro, MD
Arch Intern Med. 1998;158(6):679. doi:.

Editor's Correspondence | 
Charles B. Upshaw Jr, MD
Arch Intern Med. 1998;158(6):679-680. doi:.

Original Investigation |  FREE
Philip A. Wolf, MD; Janet B. Mitchell, PhD; Colin S. Baker, MPP; et al.
Arch Intern Med. 1998;158(3):229-234. doi:10.1001/archinte.158.3.229.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA
From The Medical Letter on Drugs and Therapeutics  | 
Rethinking Warfarin for Atrial Fibrillation

JAMA
JAMA Clinical Evidence Synopsis  | 
Factor Xa Inhibitors vs Warfarin for Preventing Stroke and Thromboembolism in Patients With Atrial Fibrillation
Karsten M. H. Bruins Slot, MD, PhD; Eivind Berge, MD, PhD
JAMA
Editorial  | 
Warfarin Treatment in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease:  Sins of Omission or Commission?
Wolfgang C. Winkelmayer, MD, MPH, ScD; Mintu P. Turakhia, MD, MAS
JAMA
Original Investigation  | 
Warfarin, Kidney Dysfunction, and Outcomes Following Acute Myocardial Infarction in Patients With Atrial Fibrillation
Juan Jesús Carrero, PhD(Pharm and Med); Marie Evans, MD, PhD; Karolina Szummer, MD, PhD; et al.